ClinicalTrials.Veeva

Menu

Primary Prevention ICD French Registry (DAI-PP)

C

Clinique Pasteur

Status

Completed

Conditions

Evaluation of Primary Prevention ICD in Real Life

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The indication of implantable cardioverter defibrillator (ICD) therapy for primary prevention of sudden cardiac death has been introduced later in France than in other parts of the World. Overall, we aimed to assess the risk-benefit ratio of this strategy over a 10 year period.

Enrollment

5,576 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Coronary artery disease or dilated cardiomyopathy with low ejection fraction implanted with an ICD in the setting of primary prevention (criteria at the discretion of the physician)

Exclusion criteria

  • Setting of secondary prevention
  • Other cardiopathies such as congenital, channelopathies, valvulopathies

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems